By synthesizing findings from neurobiological, clinical, and therapeutic studies, we seek to enhance our understanding of the complex interplay between oxytocin function and BPD symptomatology, ultimately highlighting potential avenues for future research and therapeutic interventions aimed at improving outcomes for individuals affected by this challenging disorder. The gene discussed is OXT; the disease is Borderline personality disorder.